BONE MARROW TRANSPLANTATION VERSUS IMMUNOSUPPRESSIVE THERAPY IN SEVERE APLASTIC ANEMIA, 1990 – 2001

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

GHAVAMZADEH ARDESHIR; IRAVANI M.; JAHANI M.; MOUSAVI A.; VAFAIEZADEH F.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: ARCHIVES OF IRANIAN MEDICINE Year:2004 | Volume:7 | Issue:4 Page(s): 272-278

Download Full-Text

View:

400

Download:

174

Cites:

Information Journal Paper

Title

BONE MARROW TRANSPLANTATION VERSUS IMMUNOSUPPRESSIVE THERAPY IN SEVERE APLASTIC ANEMIA, 1990 – 2001

Author(s)

Keywords

ANTILYMPHOCYTE GLOBULIN (ALG) • APLASTIC ANEMIA • BONE MARROW TRANSPLANTATION (BMT) • CYCLOSPORIN

Abstract

Background – Bone marrow transplantation (BMT) and immunosuppressive therapy are two choices of therapy for aplastic anemia. In BMT, abnormal cells are replaced by normal donor’s hematopoetic stem cells in those patients who have an HLA-identical match donor and are aged < 45 years old. In immunosuppressive therapy, antilymphocyte globulin (ALG) and cyclosporin are used in patients who do not have an HLA-identical match donor and are aged > 45 years old. Methods – In this study we compared these two modalities of treatment in acquired severe aplastic anemia. We had 70 patients in two groups. Twenty-nine patients had completed BMT and 41 patients had completed non-BMT treatment. The conditioning regimen in BMT group was cyclophosphamide plus ALG. Patients with severe aplastic anemia who had been referred to the Hematology Clinic of Shariati Hospital from 1990 through 2001, were selected according to age (< 45 or > 45 years) and presence of HLA match donor. Ethical considerations were strictly followed. Data were analyzed by SPSS version 10. Survival probabilities were estimated using Kaplan-Meier method. Results – The 5 years overall survival in BMT group was 67% and in cyclosporin group was 36.6% and we found that after the day 200 posttherapy overall survival in BMT group was higher in comparison with non-BMT treatment (p = 0.02). Conclusion – BMT has the best results and long-term survival in severe aplastic anemia patients.

Cites

No record.

References

No record.

Cite

APA: Copy

GHAVAMZADEH, ARDESHIR, IRAVANI, M., JAHANI, M., MOUSAVI, A., & VAFAIEZADEH, F.. (2004). BONE MARROW TRANSPLANTATION VERSUS IMMUNOSUPPRESSIVE THERAPY IN SEVERE APLASTIC ANEMIA, 1990 – 2001. ARCHIVES OF IRANIAN MEDICINE, 7(4), 272-278. SID. https://sid.ir/paper/279953/en

Vancouver: Copy

GHAVAMZADEH ARDESHIR, IRAVANI M., JAHANI M., MOUSAVI A., VAFAIEZADEH F.. BONE MARROW TRANSPLANTATION VERSUS IMMUNOSUPPRESSIVE THERAPY IN SEVERE APLASTIC ANEMIA, 1990 – 2001. ARCHIVES OF IRANIAN MEDICINE[Internet]. 2004;7(4):272-278. Available from: https://sid.ir/paper/279953/en

IEEE: Copy

ARDESHIR GHAVAMZADEH, M. IRAVANI, M. JAHANI, A. MOUSAVI, and F. VAFAIEZADEH, “BONE MARROW TRANSPLANTATION VERSUS IMMUNOSUPPRESSIVE THERAPY IN SEVERE APLASTIC ANEMIA, 1990 – 2001,” ARCHIVES OF IRANIAN MEDICINE, vol. 7, no. 4, pp. 272–278, 2004, [Online]. Available: https://sid.ir/paper/279953/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops